These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8999313)

  • 1. [Detection of the functionally active domains in the molecule of the lethal factor of the anthrax exotoxin].
    Noskov AN; Kravchenko TB; Noskova VP
    Mol Gen Mikrobiol Virusol; 1996; (3):20-2. PubMed ID: 8999313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of the functionally active domains in the molecule of protective antigen of the anthrax exotoxin].
    Noskov AN; Kravchenko TB; Noskova VP
    Mol Gen Mikrobiol Virusol; 1996; (3):16-20. PubMed ID: 8999312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Elucidation of functionally active domains in molecules of protective antigen bacillus anthracis's toxin].
    Noskov AN; Kravchenko TB; Noskova VP
    Vestn Ross Akad Med Nauk; 1997; (6):20-4. PubMed ID: 9289273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Purification and characteristics of a protective factor from Bacillus anthracis toxin].
    Abalakin VA; Sergeeva LV; Cherkasova TD
    Biokhimiia; 1988 Feb; 53(2):283-8. PubMed ID: 3130898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Western blot analysis of the exotoxin components from Bacillus anthracis separated by isoelectric focusing gel electrophoresis.
    Little SF
    Biochem Biophys Res Commun; 2004 Apr; 317(1):294-300. PubMed ID: 15047182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the anthrax lethal factor.
    Pannifer AD; Wong TY; Schwarzenbacher R; Renatus M; Petosa C; Bienkowska J; Lacy DB; Collier RJ; Park S; Leppla SH; Hanna P; Liddington RC
    Nature; 2001 Nov; 414(6860):229-33. PubMed ID: 11700563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of bacterial exotoxins. The case of botulinum, tetanus, anthrax, pertussis and cholera toxins.
    Pasechnik VA; Shone CC; Hambleton P
    Bioseparation; 1992-1993; 3(5):267-83. PubMed ID: 1369426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin.
    Drum CL; Yan SZ; Bard J; Shen YQ; Lu D; Soelaiman S; Grabarek Z; Bohm A; Tang WJ
    Nature; 2002 Jan; 415(6870):396-402. PubMed ID: 11807546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the anthrax toxin protective antigen.
    Petosa C; Collier RJ; Klimpel KR; Leppla SH; Liddington RC
    Nature; 1997 Feb; 385(6619):833-8. PubMed ID: 9039918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the cellular receptor for anthrax toxin.
    Bradley KA; Mogridge J; Mourez M; Collier RJ; Young JA
    Nature; 2001 Nov; 414(6860):225-9. PubMed ID: 11700562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized production and purification of Bacillus anthracis lethal factor.
    Park S; Leppla SH
    Protein Expr Purif; 2000 Apr; 18(3):293-302. PubMed ID: 10733882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of anthrax edema factor from Escherichia coli and identification of residues required for binding to anthrax protective antigen.
    Kumar P; Ahuja N; Bhatnagar R
    Infect Immun; 2001 Oct; 69(10):6532-6. PubMed ID: 11553601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis.
    Gupta P; Singh A; Chauhan V; Bhatnagar R
    Biochem Biophys Res Commun; 2001 Jan; 280(1):158-63. PubMed ID: 11162493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analyses of murine macrophages treated with Bacillus anthracis lethal toxin.
    Sapra R; Gaucher SP; Lachmann JS; Buffleben GM; Chirica GS; Comer JE; Peterson JW; Chopra AK; Singh AK
    Microb Pathog; 2006; 41(4-5):157-67. PubMed ID: 16950595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo.
    Pini A; Runci Y; Falciani C; Lelli B; Brunetti J; Pileri S; Fabbrini M; Lozzi L; Ricci C; Bernini A; Tonello F; Dal Molin F; Neri P; Niccolai N; Bracci L
    Biochem J; 2006 Apr; 395(1):157-63. PubMed ID: 16398644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-step purification of recombinant anthrax lethal factor from periplasm of Escherichia coli.
    Chang HH; Tsai MF; Chung CP; Chen PK; Hu HI; Kau JH; Huang HH; Lin HC; Sun DS
    J Biotechnol; 2006 Nov; 126(3):277-85. PubMed ID: 16797097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational insights into the interaction of the anthrax lethal factor with the N-terminal region of its substrates.
    Joshi M; Ebalunode JO; Briggs JM
    Proteins; 2009 May; 75(2):323-35. PubMed ID: 18831046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Man bites dog.
    Meador WE; Quiocho FA
    Nat Struct Biol; 2002 Mar; 9(3):156-8. PubMed ID: 11875510
    [No Abstract]   [Full Text] [Related]  

  • 19. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.
    Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD
    J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of non-toxic deletion mutants of protective antigen from Bacillus anthracis.
    Rhie GE; Park YM; Han JS; Yu JY; Seong WK; Oh HB
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):341-7. PubMed ID: 16019195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.